Company Profiles

driven by the PitchBook Platform

Regentis Biomaterials

Description

Operator of a tissue repair company. The company focuses on developing and commercializing an innovative hydrogel platform for the repair of damaged tissue.

2004

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$15M

Latest Deal Amount

$33.1M

Total Amount Raised

Description

Operator of a tissue repair company. The company focuses on developing and commercializing an innovative hydrogel platform for the repair of damaged tissue.

Website:

www.regentis.co.il

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

2 Ha'ilan Street Northern Industrial Zone, P.O.Box 260 Or-Akiva 3060000Israel +972 (0)4 626 5502
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Regentis Biomaterials's full profile, request a free trial.

    Regentis Biomaterials Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Regentis Biomaterials Investors (11)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Crossroad FCPVenture CapitalMinority000 0000000 0000
    DSM VenturingCorporate Venture CapitalMinority000 0000000 0000
    Generali Investments EuropeLimited PartnerMinority000 0000000 0000
    Haisco Pharmaceutical GroupCorporationMinority000 0000000 0000
    Medica Venture PartnersVenture CapitalMinority000 0000000 0000
    Crossroad FCP Venture Capital
    DSM Venturing Corporate Venture Capital
    Generali Investments Europe Limited Partner
    Haisco Pharmaceutical Group Corporation
    Medica Venture Partners Venture Capital

    Regentis Biomaterials Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Alastair Clemow Ph.DChief Executive Officer & President
    Livnat Ben-ZurIsrael Office General Manager & Vice President, Business Development
    Dror SeliktarCo-Founder & Chief Scientific Officer
    Roni Wechsler Ph.DVice President, Research & Development
    Alastair Clemow Ph.D Chief Executive Officer & President
    Livnat Ben-Zur Israel Office General Manager & Vice President, Business Development
    Dror Seliktar Co-Founder & Chief Scientific Officer
    Roni Wechsler Ph.D Vice President, Research & Development

    Regentis Biomaterials Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Ehud Geller Ph.DMedica Venture PartnersFounder & Managing Partner000 0000
    Eli Hazum Ph.DMedica Venture PartnersGeneral Partner & Chief Scientific Officer000 0000
    Ian FreelanceDSM VenturingSenior Investment Manager000 0000
    Jeff DykanSCP Vitalife PartnersManaging Partner000 0000
    Keith ValentineSelfBoard Member000 0000
    Ehud Geller Ph.D Founder & Managing Partner Medica Venture Partners
    Eli Hazum Ph.D General Partner & Chief Scientific Officer Medica Venture Partners
    Ian Freelance Senior Investment Manager DSM Venturing
    Jeff Dykan Managing Partner SCP Vitalife Partners
    Keith Valentine Board Member Self
    Request full access to PitchBook